Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Capital Expenditures
Fusion Antibodies PLC
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Capital Expenditures
£244k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Capital Expenditures
-£27.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Capital Expenditures
-£1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Capital Expenditures
-£4.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-77%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Capital Expenditures
-£2.5m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Capital Expenditures
-£5.2m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-136%
|
CAGR 10-Years
-67%
|
See Also
What is Fusion Antibodies PLC's Capital Expenditures?
Capital Expenditures
244k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Capital Expenditures amounts to 244k GBP.